Prosecution Insights
Last updated: May 29, 2026

Keygene N V

7 pending office actions • 5 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days

Portfolio Summary

7
Total Pending OAs
5
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
3
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (3)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
5
Medium (71%)
1
Easy (14%)
1
Unknown (14%)

Rejection Statute Mix

BucketCases
§103 only5 (71%)
§112 only1 (14%)
No statute on record1 (14%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

7
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PAGE, BRENT T 1 82.5% +10.7%
STOCKDALE, JESSICA NICOLE 1 43.3% +44.0%
KEOGH, MATTHEW R 1 78.6% +14.0%
ZHONG, WAYNESHAOBIN 1 72.2% +22.2%
LAFAVE, ELIZABETH ROSE 1 55.3% +56.3%
BAKSHI, PANCHAM 1 77.0% +30.1%
LU, FRANK WEI MIN 1 63.0% +66.3%

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
17843612 NGS LIBRARY PREPARATION USING COVALENTLY CLOSED NUCLEIC ACID MOLECULE ENDS LAFAVE, ELIZABETH ROSE 43d overdue
17837904 SEMI-SOLID STATE NUCLEIC ACID MANIPULATION BAKSHI, PANCHAM 16d overdue
17297859 TARGETED ENRICHMENT BY ENDONUCLEASE PROTECTION LU, FRANK WEI MIN 8d overdue
18743454 DOUBLE DECAPITATION OF PLANTS STOCKDALE, JESSICA NICOLE 13d
18757549 Delivery systems for TNE PAGE, BRENT T 15d
18737058 METHOD TO INCREASE POLLEN FERTILITY KEOGH, MATTHEW R 28d
18602867 COMPLEX TRAITS USING TISSUE TECHNOLOGY ZHONG, WAYNESHAOBIN 72d

Top Art Units

Art UnitApps
1663 3
1662 1
1684 1
1623 1
1683 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18757549 Delivery systems for TNE PAGE, BRENT T 1663 Other Non-Final OA 15d Pending Jun 28, 2024
18743454 DOUBLE DECAPITATION OF PLANTS STOCKDALE, JESSICA NICOLE 1663 §103 Non-Final OA 13d Pending Jun 14, 2024
18737058 METHOD TO INCREASE POLLEN FERTILITY KEOGH, MATTHEW R 1663 §112 Non-Final OA 28d Pending Jun 07, 2024
18602867 COMPLEX TRAITS USING TISSUE TECHNOLOGY ZHONG, WAYNESHAOBIN 1662 §103 Non-Final OA 72d Pending Mar 12, 2024
17843612 NGS LIBRARY PREPARATION USING COVALENTLY CLOSED NUCLEIC ACID MOLECULE ENDS LAFAVE, ELIZABETH ROSE 1684 §103 Final Rejection 43d overdue Pending Jun 17, 2022
17837904 SEMI-SOLID STATE NUCLEIC ACID MANIPULATION BAKSHI, PANCHAM 1623 §103 Final Rejection 16d overdue Pending Jun 10, 2022
17297859 TARGETED ENRICHMENT BY ENDONUCLEASE PROTECTION LU, FRANK WEI MIN 1683 §103 Non-Final OA 8d overdue Pending May 27, 2021

Managing Keygene N V's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month